Literature DB >> 32679175

Regional differences in use of immune-modulating catechins should be investigated regarding COVID-19.

M Catherine DeSoto1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32679175      PMCID: PMC7362853          DOI: 10.1016/j.bbi.2020.07.012

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


× No keyword cloud information.
Dear Editor, Brain, Behavior and Immunity, I read with interest the in-press article, “The impact of nutrition on COVID-19 susceptibility and long-term consequences” by Butler and Barreintos. As noted, obesity is an important risk factor regarding COVID-19. Obesity itself is a pro-inflammatory condition. While Butler focused on consuming fats and T-cell activity as mediators, other possible mechanisms exist. Because excessive cascading release of inflammatory cytokines (cytokine storm) plays a role in mortality versus recovery, tristetraprolin (TTP/aka ZFP36) may be an important specific mediator. A sex difference in ZFP26 allele’s correlation to glucose levels (Bouchard et al., 2007) is interesting given that sex differences in COVID-19 risk are emerging. Although beyond the scope of this letter, the effect of TTP on the decay of tumor necrosis factor (TNF, key inflammatory cytokine) has been well-detailed, including by comparing the response of wild-type and TTP knock-out mice to TNF-exposure. Decay of TNF-transcripts slows when TTP is deficient, and the gold-standard knock-out model technique points squarely to TTP function. In sum, TTP plays a primary role in helpfully regulating the response to TNF release when the immune cells respond to a viral invasion, and its role has been well-characterized (Qiu et al., 2015). TTP expression is affected by dietary substances, such as cinnamon polyphenol extract, and green tea extracts (Cao et al., 2007). Although clinical trials are obviously needed to establish causal relationship specific to COVID-19, this is not the same as knowing nothing. We can say: Obesity is a risk factor for COVID-19 complications. Obesity is a pro-inflammatory condition. A run-away inflammatory response (cytokine storm) has been found to differentiate severe cases. Therefore inflammation appears important in understanding COVID-19 reactions. The following might be important: A high rate of mortality occurs in some locations (Italy, U.S.) but not others (e.g. Taiwan, Japan). TTP regulates cytokine response to pro-inflammatory stimuli. There is a body of research on substances that impact TTP. China, Indonesia and Japan are the top consumers of green tea, and persons in Europe, USA, and Africa seldom drink green tea. Death rates by selected country are listed in Table 1 .
Table 1

COVID deaths per capita. Countries with more than 100 total deaths are included. The 10 countries with the highest death rates as of June 26, 2020 (10) are listed along with three countries that consume high levels of green tea.

CountryNumber of COVID DeathsCOVID Deaths/100 K POP.
Belgium9,72685.15
United Kingdom43,31465.14
Spain28,33060.63
Italy34,67857.38
Sweden5,23051.36
France29,75544.42
United States124,41038.03
Ireland1,72735.58
Netherlands6,11935.51
Peru8,76127.39
Japan9710.77
China4,6410.33
Indonesia2,6200.98
COVID deaths per capita. Countries with more than 100 total deaths are included. The 10 countries with the highest death rates as of June 26, 2020 (10) are listed along with three countries that consume high levels of green tea. Butler wrote, “Studies show that consuming healthy foods has a rapid anti-inflammatory effect, even in the presence of obesity pathology” and it is “critical to consider the impact of … unhealthy diets on the susceptibility to COVID-19 and recovery.” Absolutely. Let’s extend this to considering mechanisms and which food cofactors are most important to specific needs. Research in main-stream journals has documented the mechanisms underlying food-based substances’ antiviral effects. This is not new, it is not trendy: it is the data (Song et al., 2007, Ide et al., 2016). Although it is not incorrect to state there is no evidence food-based substances have any effect on Covid-19, this is because it’s a novel virus that emerged a few months ago. Conversely, it is incorrect to say there is no evidence these substances possess antiviral activity relevant to flu viruses, corona viruses, and immunity (Song et al., 2007, Ide et al., 2016). Wash your hands, and eat well (as Butler articulates), but also be aware of the strong research on specific substances found in specific foods with attention to the mechanisms of their antiviral actions.
  5 in total

Review 1.  Anti-influenza Virus Effects of Catechins: A Molecular and Clinical Review.

Authors:  Kazuke Ide; Yohei Kawasaki; Koji Kawakami; Hiroshi Yamada
Journal:  Curr Med Chem       Date:  2016       Impact factor: 4.530

2.  Tristetraprolin (TTP) coordinately regulates primary and secondary cellular responses to proinflammatory stimuli.

Authors:  Lian-Qun Qiu; Wi S Lai; Alyce Bradbury; Darryl C Zeldin; Perry J Blackshear
Journal:  J Leukoc Biol       Date:  2015-02-05       Impact factor: 4.962

3.  Visceral adipose tissue zinc finger protein 36 mRNA levels are correlated with insulin, insulin resistance index, and adiponectinemia in women.

Authors:  Luigi Bouchard; Marie-Claude Vohl; Yves Deshaies; Caroline Rhéaume; Marleen Daris; André Tchernof
Journal:  Eur J Endocrinol       Date:  2007-10       Impact factor: 6.664

4.  Biological evaluation of anti-influenza viral activity of semi-synthetic catechin derivatives.

Authors:  Jae Min Song; Ki Duk Park; Kwang Hee Lee; Young Ho Byun; Ju Hee Park; Sung Han Kim; Jae Hong Kim; Baik Lin Seong
Journal:  Antiviral Res       Date:  2007-08-01       Impact factor: 5.970

5.  Green tea increases anti-inflammatory tristetraprolin and decreases pro-inflammatory tumor necrosis factor mRNA levels in rats.

Authors:  Heping Cao; Meghan A Kelly; Frank Kari; Harry D Dawson; Joseph F Urban; Sara Coves; Anne M Roussel; Richard A Anderson
Journal:  J Inflamm (Lond)       Date:  2007-01-05       Impact factor: 4.981

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.